Mori Satoshi
Department of Orthopedic Surgery, Faculty of Medicine, Kagawa University.
Clin Calcium. 2004 Oct;14(10):33-8.
Recently Bone quality has been recognized as an important contributing factor of bone strength, as clearly stated in NIH (National Institute of Health) consensus development panel of 2000 that bone strength reflects both bone density and bone quality. Bone quality refers to architecture, turnover, damage accumulation, mineralization and matrix. In the treatment of osteoporosis anti-resorptive agents increase bone strength with decreasing bone turnover. It is important to control bone turnover within favorable range to increase bone strength without deterioration of bone quality.
最近,骨质已被公认为骨强度的一个重要影响因素,正如2000年美国国立卫生研究院(NIH)共识发展小组明确指出的那样,骨强度反映了骨密度和骨质。骨质指的是结构、更新、损伤积累、矿化和基质。在骨质疏松症的治疗中,抗吸收药物通过降低骨转换来增加骨强度。将骨转换控制在有利范围内对于在不降低骨质的情况下增加骨强度很重要。